Patents Assigned to PHARMASUM THERAPEUTICS AS
  • Benzothiazole derivatives as DYRK1 inhibitors
    Patent number: 10927106
    Abstract: The present invention relates to compounds of Formula (I), which are DYRK1A and/or DYRK1B inhibitors, and their use in the treatment of neurodegenerative disorders such as Alzheimer's disease (AD) and Parkinson's disease (PD), metabolic disorders such as Metabolic Syndrome or diabetes mellitus, and cancer.
    Type: Grant
    Filed: October 12, 2017
    Date of Patent: February 23, 2021
    Assignee: PHARMASUM THERAPEUTICS AS
    Inventors: John Sigurd Svendsen, Wenche Stensen, Roderick Alan Porter